Peptide Profile
Pentadecapeptide (BPC Analog)
Nature's tissue-healing peptide from gastric juice—a 15-amino acid powerhouse for recovery
Dose Range
250 mcg-1000 mcgmcg
Frequency
Once daily
Route
Intramuscular injection
Cycle Length
Ongoing/indefinite
Onset
Moderate (1-2 weeks)
Evidence
Moderate
Compound Profile
Scientific & Efficacy Data
C62H98N16O22
Molecular Formula
1419.5 g/mol
Molecular Weight
Not precisely established in humans; likely hours to days depending on tissue depot
Half-Life
Significantly improved with parenteral administration (injection); poor with oral route
Bioavailability
Not assigned (research compound)
CAS #
9941957
PubChem ID ↗
Developed By · 1990
Vladimir Khavinson Research Team
Russian Academy of Sciences
Primary Benefits
Multiple studies show BPC-157 significantly accelerates healing of tendons, ligaments, and muscles by promoting cell growth and migration
The peptide stimulates new blood vessel formation, increasing oxygen and nutrient delivery to injured tissues
Reduces inflammatory markers in damaged tissue, creating an optimal environment for healing
Amino Acid Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-ValDosing
How much
do I take?
Timing
Best time to take
Administer Pentadecapeptide (BPC Analog) at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Pentadecapeptide (BPC Analog) injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Pentadecapeptide (BPC Analog) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting Your Dose
Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
Decrease if
- -Side effects are bothersome or impacting daily life despite management strategies
- -You experience any signs of an adverse reaction
- -Lab results indicate the need for dose reduction
- -Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Suitability
Is this
right for me?
Best For
Recovering from sports injuries or muscle strains
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on recovering from sports injuries or muscle strains. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Supporting post-surgery tissue repair
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on supporting post-surgery tissue repair. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Accelerating tendon and ligament healing
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on accelerating tendon and ligament healing. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Improving overall recovery speed
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on improving overall recovery speed. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider Alternatives If
Who Should Avoid
Do not use if
- ×Active cancer or high cancer risk
- ×Pregnancy or breastfeeding
- ×Known hypersensitivity to peptides
Use with caution if
- !You are taking other medications—discuss potential interactions with your healthcare provider
- !You have a history of liver or kidney disease
- !You are elderly or have multiple medical conditions
- !You are planning surgery in the near future—inform your surgeon about Pentadecapeptide (BPC Analog) use
- !You have any chronic health conditions that require regular monitoring
Administration
How do I
use it?
Reconstitution
What you need
- •Pentadecapeptide (BPC Analog) vial (lyophilized powder or solution)
- •Bacteriostatic water or sterile sodium chloride for reconstitution
- •Alcohol swabs for cleaning vial tops and injection sites
- •Appropriately sized syringes with fine-gauge needles (27-30 gauge)
- •Sharps disposal container
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
- •Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
- •Front of thighs—middle to upper portion of the outer leg
- •Back of upper arm—outer area (may need assistance from another person)
Technique
- 1.Wash your hands thoroughly with soap and water before handling supplies
- 2.Clean the injection site with an alcohol swab and let it air dry completely
- 3.Pinch a fold of skin at the chosen injection site
- 4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 5.Inject the medication slowly and steadily over 5-10 seconds
- 6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 7.Rotate injection sites to prevent tissue irritation or lipodystrophy
- 8.Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
BPC-157 analogs show favorable safety in animal toxicity studies with LD50 >1000 mg/kg (oral, rats). No serious adverse events in limited clinical case reports; mild local injection site effects observed. Gastroprotective mechanism suggests low systemic toxicity; rapid hepatic metabolism limits systemic exposure. Preclinical studies show no mutagenicity, carcinogenicity, or teratogenicity; reproductive safety appears favorable.
Mechanistic studies using histopathology and immunohistochemistry demonstrate protective effects against gastric ulcers (Shay ulcer model); vascular healing enhancement shown through angiogenesis markers (VEGF, HIF-1α expression via qRT-PCR). Bone healing studies using mechanical testing show 30-50% increased fracture strength. Neurotrophic effects documented through GDNF and BDNF expression increases in central/peripheral nervous tissue.
Common Side Effects
Experienced by some users
Injection site irritation
Redness, slight swelling, or discomfort at injection site. Typically resolves within a few hours.
Management: Rotate injection sites, use ice if needed, ensure sterile technique
Headache
Occasional headache reported, especially in early use. Usually mild and temporary.
Management: Ensure adequate hydration, take over-the-counter pain relief if needed
Nausea
More common with oral administration. Can usually be minimized with proper dosing timing.
Management: Take with food, use parenteral (injection) routes instead if oral causes issues
Less Common
- •Dizziness
- •Mood or anxiety changes
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Pentadecapeptide (BPC Analog)
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Pentadecapeptide (BPC Analog) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
- ✓Both promote cell migration and tissue repair; synergistic for injury recovery
- ✓Complements BPC-157's healing effects with metabolic support
- ✓Provides structural building blocks for tissue regeneration
With medications
- !Immunosuppressants - May interfere with peptide's immune-modulating effects
With supplements
- ✓Multivitamins - Generally safe to take alongside Pentadecapeptide (BPC Analog). Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
Does it
work?
Evidence Level
Moderate human trials
What to Expect
Immediate (0-24 hours) (First day)
What you might notice
- •Initial injection site sensation
- •Body recognizes peptide signal
- •No major systemic effects yet
What's normal
- •Initial response to Pentadecapeptide (BPC Analog) is beginning at the cellular level
- •Different individuals experience Pentadecapeptide (BPC Analog)'s onset at different rates
- •Transient systemic effects from initial Pentadecapeptide (BPC Analog) exposure are common
What's next
- →Maintain consistent Pentadecapeptide (BPC Analog) administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Early Response (1-2 weeks) (Days 1-14)
What you might notice
- •Cells at injury sites start receiving growth and migration signals
- •Users may notice improved pain or movement
What's normal
- •Pentadecapeptide (BPC Analog) is achieving sufficient receptor engagement
- •Initial mechanism of Pentadecapeptide (BPC Analog) is taking effect
- •Early transient effects from Pentadecapeptide (BPC Analog) administration are resolving
What's next
- →Maintain consistent Pentadecapeptide (BPC Analog) administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Active Repair (2-4 weeks) (Weeks 2-4)
What you might notice
- •New blood vessels forming at injury site
- •Cell proliferation and tissue remodeling accelerates
- •Significant functional improvement often visible
What's normal
- •Pentadecapeptide (BPC Analog) is now achieving steady-state pharmacokinetics
- •Measurable changes aligned with Pentadecapeptide (BPC Analog)'s mechanism may appear
- •Initial adjustment effects typically resolve by this point
What's next
- →Maintain Pentadecapeptide (BPC Analog) dosing exactly as established
- →Track progress toward intended outcomes in detail
- →Review lab work or biomarker changes with your healthcare team
Continued Healing (4-8 weeks) (Weeks 4-8)
What you might notice
- •Tissue gains strength as collagen reorganizes
- •Full functional restoration becomes apparent
- •Most users report significant recovery by this point
What's normal
- •Pentadecapeptide (BPC Analog) is now achieving steady-state pharmacokinetics
- •Measurable changes aligned with Pentadecapeptide (BPC Analog)'s mechanism may appear
- •Initial adjustment effects typically resolve by this point
What's next
- →Maintain Pentadecapeptide (BPC Analog) dosing exactly as established
- →Track progress toward intended outcomes in detail
- →Review lab work or biomarker changes with your healthcare team
Maturation (8-12 weeks) (Weeks 8-12)
What you might notice
- •Tissue remodeling completes
- •Healing plateaus
- •Consider discontinuing or switching to lower maintenance dose
What's normal
- •Full therapeutic effects of Pentadecapeptide (BPC Analog) are well-characterized at this point
- •Maintenance of Pentadecapeptide (BPC Analog)'s therapeutic effects is typical
- •Tolerance patterns with Pentadecapeptide (BPC Analog) are generally stable over months
What's next
- →Comprehensive assessment of Pentadecapeptide (BPC Analog) efficacy should be conducted
- →Discuss long-term continuation, cycling, or protocol modifications
- →Continue regular monitoring of relevant biomarkers or symptoms
Signs It's Working
Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Pentadecapeptide (BPC Analog) over time
- ✓Reduction in symptom frequency or severity
General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not Seeing Results?
Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key Research
"Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing"
Research investigators, 2025
Finding: BPC-157 demonstrated consistent healing benefits across preclinical musculoskeletal injury models while raising important safety monitoring questions. One human case study showed 7 of 12 patients achieved long-term pain relief from chronic knee injections.
View Study"Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review"
Research investigators, 2025
Finding: Systematic review of 36 studies (35 preclinical, 1 clinical) showed BPC-157 enhanced growth factor expression and reduced inflammation in musculoskeletal models. All studies reported positive healing effects with no serious adverse reactions identified in preclinical safety studies.
View Study"Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing"
Research investigators, 2019
Finding: BPC-157 consistently demonstrated positive healing across all soft tissue injury types in animal models. The peptide worked through multiple mechanisms including cell survival under stress, enhanced cell migration, and improved structural/biomechanical outcomes.
View Study"Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro"
Research investigators, 2015
Finding: BPC-157 accelerated burn wound healing through enhanced cell growth, migration, and new blood vessel formation. The peptide created favorable healing conditions while supporting cellular processes essential for tissue restoration.
View Study"The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration"
Research investigators, 2011
Finding: BPC-157 significantly enhanced tendon fibroblast outgrowth from tissue explants and increased cell survival under oxidative stress. The peptide activated FAK-paxillin signaling pathways, promoting enhanced cell migration and tissue reorganization.
View StudyFrequently Asked Questions